AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's ...

Antimicrobials, vaccines, and anti-inflammatories are associated with a reduced risk for Alzheimer disease and dementia, while antipsychotics and drugs for diabetes are associated with an increased ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

A new EPA ban on TCE, a common industrial cleaning agent and contaminant, begins this year. UCSF’s Samuel Goldman, who led groundbreaking research to link TCE to Parkinson’s Disease, talks about the ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

A study reveals that smartwatch data can predict psychiatric illnesses, uncover genetic links, and improve treatment options, ...

A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s ...

Their current study reveals that having diabetes, exposure to traffic-related air pollution (in the form of nitrogen dioxide) ...

“The advantage of blarcamesine lies in its small oral formulation, which offers clinical benefits for cognition and neurodegeneration ... Alzheimer's disease, Parkinson's disease, schizophrenia ...

The UPV/EHU's Neurochemistry and Neurodegeneration group has come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents.